| ANOVA | one-way analysis of variance |
| AFM | atomic force microscopy |
| AUC 0–90min | area under drug concentration–time curve between 0 and 90 min |
| BA | bioavailability |
| BAC | benzalkonium chloride |
| CavME | caveolae-dependent endocytosis |
| CME | clathrin-dependent endocytosis |
| DDS | Drug-delivery systems |
| HPCD | 2-hydroxypropyl-β-cyclodextrin |
| IMC | indomethacin |
| IMC-MCs | dispersions containing indomethacin microcrystals |
| IMC-NCs | indomethacin nanocrystals |
| IMC-NC/PLF | in situ gel incorporating indomethacin nanocrystals with PLF-127 |
| IMC-NPs | ophthalmic dispersions containing indomethacin nanocrystals |
| ISG | in situ gel |
| LF | lacrimal fluid |
| MC | methylcellulose |
| MP | micropinocytosis |
| NCs | nanocrystals |
| NPs | nanoparticles |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| PLF-127 | Pluronic F-127 |
| SE | standard error |